Global Marine Biopharmaceutical Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

SKU ID : QYR-22146734 | Publishing Date : 05-Dec-2022 | No. of pages : 121

Detailed TOC of Global Marine Biopharmaceutical Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Marine Biopharmaceutical Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Drugs
        1.2.3 Health Supplement
    1.3 Market by Application
        1.3.1 Global Marine Biopharmaceutical Market Growth Rate by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital & Clinic
        1.3.3 Pharmacy
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Market Perspective
    2.1 Global Marine Biopharmaceutical Market Size (2017-2028)
    2.2 Marine Biopharmaceutical Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
    2.3 Global Marine Biopharmaceutical Market Size by Region (2017-2022)
    2.4 Global Marine Biopharmaceutical Market Size Forecast by Region (2023-2028)
    2.5 Global Top Marine Biopharmaceutical Countries Ranking by Market Size
3 Marine Biopharmaceutical Competitive by Company
    3.1 Global Marine Biopharmaceutical Revenue by Players
        3.1.1 Global Marine Biopharmaceutical Revenue by Players (2017-2022)
        3.1.2 Global Marine Biopharmaceutical Market Share by Players (2017-2022)
    3.2 Global Marine Biopharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Company Covered: Ranking by Marine Biopharmaceutical Revenue
    3.4 Global Marine Biopharmaceutical Market Concentration Ratio
        3.4.1 Global Marine Biopharmaceutical Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Marine Biopharmaceutical Revenue in 2021
    3.5 Global Marine Biopharmaceutical Key Players Head office and Area Served
    3.6 Key Players Marine Biopharmaceutical Product Solution and Service
    3.7 Date of Enter into Marine Biopharmaceutical Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Global Marine Biopharmaceutical Breakdown Data by Type
    4.1 Global Marine Biopharmaceutical Historic Revenue by Type (2017-2022)
    4.2 Global Marine Biopharmaceutical Forecasted Revenue by Type (2023-2028)
5 Global Marine Biopharmaceutical Breakdown Data by Application
    5.1 Global Marine Biopharmaceutical Historic Market Size by Application (2017-2022)
    5.2 Global Marine Biopharmaceutical Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Marine Biopharmaceutical Revenue by Company (2020-2022)
    6.2 North America Marine Biopharmaceutical Revenue by Type (2017-2028)
    6.3 North America Marine Biopharmaceutical Revenue by Application (2017-2028)
    6.4 North America Marine Biopharmaceutical Revenue by Country (2017-2028)
        6.4.1 United States
        6.4.2 Canada
7 Europe
    7.1 Europe Marine Biopharmaceutical Revenue by Company (2020-2022)
    7.2 Europe Marine Biopharmaceutical Revenue by Type (2017-2028)
    7.3 Europe Marine Biopharmaceutical Revenue by Application (2017-2028)
    7.4 Europe Marine Biopharmaceutical Revenue by Country (2017-2028)
        7.4.1 Germany
        7.4.2 France
        7.4.3 U.K.
        7.4.4 Italy
        7.4.5 Russia
8 Asia Pacific
    8.1 Asia Pacific Marine Biopharmaceutical Revenue by Company (2020-2022)
    8.2 Asia Pacific Marine Biopharmaceutical Revenue by Type (2017-2028)
    8.3 Asia Pacific Marine Biopharmaceutical Revenue by Application (2017-2028)
    8.4 Asia Pacific Marine Biopharmaceutical Revenue by Region (2017-2028)
        8.4.1 China
        8.4.2 Japan
        8.4.3 South Korea
        8.4.4 India
        8.4.5 Australia
        8.4.6 China Taiwan
        8.4.7 Indonesia
        8.4.8 Thailand
        8.4.9 Malaysia
9 Latin America
    9.1 Latin America Marine Biopharmaceutical Revenue by Company (2020-2022)
    9.2 Latin America Marine Biopharmaceutical Revenue by Type (2017-2028)
    9.3 Latin America Marine Biopharmaceutical Revenue by Application (2017-2028)
    9.4 Latin America Marine Biopharmaceutical Revenue by Country (2017-2028)
        9.4.1 Mexico
        9.4.2 Brazil
        9.4.3 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Marine Biopharmaceutical Revenue by Company (2020-2022)
    10.2 Middle East and Africa Marine Biopharmaceutical Revenue by Type (2017-2028)
    10.3 Middle East and Africa Marine Biopharmaceutical Revenue by Application (2017-2028)
    10.4 Middle East and Africa Marine Biopharmaceutical Revenue by Country (2017-2028)
        10.4.1 Turkey
        10.4.2 Saudi Arabia
        10.4.3 UAE
11 Company Profiles
    11.1 Seattle Genetics
        11.1.1 Seattle Genetics Company Details
        11.1.2 Seattle Genetics Business Overview
        11.1.3 Seattle Genetics Marine Biopharmaceutical Products and Services
        11.1.4 Seattle Genetics Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022)
        11.1.5 Seattle Genetics Marine Biopharmaceutical SWOT Analysis
        11.1.6 Seattle Genetics Recent Developments
    11.2 DSM
        11.2.1 DSM Company Details
        11.2.2 DSM Business Overview
        11.2.3 DSM Marine Biopharmaceutical Products and Services
        11.2.4 DSM Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022)
        11.2.5 DSM Marine Biopharmaceutical SWOT Analysis
        11.2.6 DSM Recent Developments
    11.3 Eisai Co
        11.3.1 Eisai Co Company Details
        11.3.2 Eisai Co Business Overview
        11.3.3 Eisai Co Marine Biopharmaceutical Products and Services
        11.3.4 Eisai Co Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022)
        11.3.5 Eisai Co Marine Biopharmaceutical SWOT Analysis
        11.3.6 Eisai Co Recent Developments
    11.4 Takeda
        11.4.1 Takeda Company Details
        11.4.2 Takeda Business Overview
        11.4.3 Takeda Marine Biopharmaceutical Products and Services
        11.4.4 Takeda Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022)
        11.4.5 Takeda Marine Biopharmaceutical SWOT Analysis
        11.4.6 Takeda Recent Developments
    11.5 BASF
        11.5.1 BASF Company Details
        11.5.2 BASF Business Overview
        11.5.3 BASF Marine Biopharmaceutical Products and Services
        11.5.4 BASF Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022)
        11.5.5 BASF Marine Biopharmaceutical SWOT Analysis
        11.5.6 BASF Recent Developments
    11.6 Amway
        11.6.1 Amway Company Details
        11.6.2 Amway Business Overview
        11.6.3 Amway Marine Biopharmaceutical Products and Services
        11.6.4 Amway Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022)
        11.6.5 Amway Marine Biopharmaceutical SWOT Analysis
        11.6.6 Amway Recent Developments
    11.7 Pfizer
        11.7.1 Pfizer Company Details
        11.7.2 Pfizer Business Overview
        11.7.3 Pfizer Marine Biopharmaceutical Products and Services
        11.7.4 Pfizer Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022)
        11.7.5 Pfizer Marine Biopharmaceutical SWOT Analysis
        11.7.6 Pfizer Recent Developments
    11.8 Pelagia (EPAX)
        11.8.1 Pelagia (EPAX) Company Details
        11.8.2 Pelagia (EPAX) Business Overview
        11.8.3 Pelagia (EPAX) Marine Biopharmaceutical Products and Services
        11.8.4 Pelagia (EPAX) Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022)
        11.8.5 Pelagia (EPAX) Marine Biopharmaceutical SWOT Analysis
        11.8.6 Pelagia (EPAX) Recent Developments
    11.9 Pharma Mar SA
        11.9.1 Pharma Mar SA Company Details
        11.9.2 Pharma Mar SA Business Overview
        11.9.3 Pharma Mar SA Marine Biopharmaceutical Products and Services
        11.9.4 Pharma Mar SA Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022)
        11.9.5 Pharma Mar SA Marine Biopharmaceutical SWOT Analysis
        11.9.6 Pharma Mar SA Recent Developments
    11.10 Croda
        11.10.1 Croda Company Details
        11.10.2 Croda Business Overview
        11.10.3 Croda Marine Biopharmaceutical Products and Services
        11.10.4 Croda Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022)
        11.10.5 Croda Marine Biopharmaceutical SWOT Analysis
        11.10.6 Croda Recent Developments
    11.11 GNC
        11.11.1 GNC Company Details
        11.11.2 GNC Business Overview
        11.11.3 GNC Marine Biopharmaceutical Products and Services
        11.11.4 GNC Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022)
        11.11.5 GNC Recent Developments
    11.12 GSK
        11.12.1 GSK Company Details
        11.12.2 GSK Business Overview
        11.12.3 GSK Marine Biopharmaceutical Products and Services
        11.12.4 GSK Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022)
        11.12.5 GSK Recent Developments
    11.13 TerSera Therapeutics
        11.13.1 TerSera Therapeutics Company Details
        11.13.2 TerSera Therapeutics Business Overview
        11.13.3 TerSera Therapeutics Marine Biopharmaceutical Products and Services
        11.13.4 TerSera Therapeutics Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022)
        11.13.5 TerSera Therapeutics Recent Developments
    11.14 Nordic Naturals
        11.14.1 Nordic Naturals Company Details
        11.14.2 Nordic Naturals Business Overview
        11.14.3 Nordic Naturals Marine Biopharmaceutical Products and Services
        11.14.4 Nordic Naturals Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022)
        11.14.5 Nordic Naturals Recent Developments
    11.15 Carlson Labs
        11.15.1 Carlson Labs Company Details
        11.15.2 Carlson Labs Business Overview
        11.15.3 Carlson Labs Marine Biopharmaceutical Products and Services
        11.15.4 Carlson Labs Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022)
        11.15.5 Carlson Labs Recent Developments
12 Marine Biopharmaceutical Market Dynamics
    12.1 Marine Biopharmaceutical Market Trends
    12.2 Marine Biopharmaceutical Market Drivers
    12.3 Marine Biopharmaceutical Market Challenges
    12.4 Marine Biopharmaceutical Market Restraints
13 Research Findings and Conclusion
14 Appendix
    14.1 Research Methodology
        14.1.1 Methodology/Research Approach
        14.1.2 Data Source
    14.2 Author Details

List of Figures, Tables and Charts Available in Global Marine Biopharmaceutical Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

List of Tables
    Table 1. Global Marine Biopharmaceutical Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Drugs
    Table 3. Key Players of Health Supplement
    Table 4. Global Marine Biopharmaceutical Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global Marine Biopharmaceutical Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
    Table 6. Global Marine Biopharmaceutical Revenue by Region (2017-2022) & (US$ Million)
    Table 7. Global Marine Biopharmaceutical Revenue Market Share by Region (2017-2022)
    Table 8. Global Marine Biopharmaceutical Revenue by Players (2017-2022) & (US$ Million)
    Table 9. Global Marine Biopharmaceutical Market Share by Players (2017-2022)
    Table 10. Global Top Marine Biopharmaceutical Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Marine Biopharmaceutical as of 2021)
    Table 11. Ranking of Global Top Marine Biopharmaceutical Companies by Revenue (US$ Million) in 2021
    Table 12. Global 5 Largest Players Market Share by Marine Biopharmaceutical Revenue (CR5 and HHI) & (2017-2022)
    Table 13. Key Players Headquarters and Area Served
    Table 14. Key Players Marine Biopharmaceutical Product Solution and Service
    Table 15. Date of Key Manufacturers Enter into Marine Biopharmaceutical Market
    Table 16. Mergers & Acquisitions, Expansion Plans
    Table 17. Global Marine Biopharmaceutical Market Size by Type (2017-2022) & (US$ Million)
    Table 18. Global Marine Biopharmaceutical Revenue Market Share by Type (2017-2022)
    Table 19. Global Marine Biopharmaceutical Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 20. Global Marine Biopharmaceutical Revenue Market Share by Type (2023-2028)
    Table 21. Global Marine Biopharmaceutical Market Size by Application (2017-2022) & (US$ Million)
    Table 22. Global Marine Biopharmaceutical Revenue Market Share by Application (2017-2022)
    Table 23. Global Marine Biopharmaceutical Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 24. Global Marine Biopharmaceutical Revenue Market Share by Application (2023-2028)
    Table 25. North America Marine Biopharmaceutical Revenue by Company (2020-2022) & (US$ Million)
    Table 26. North America Marine Biopharmaceutical Revenue by Type (2017-2022) & (US$ Million)
    Table 27. North America Marine Biopharmaceutical Revenue by Type (2023-2028) & (US$ Million)
    Table 28. North America Marine Biopharmaceutical Revenue by Application (2017-2022) & (US$ Million)
    Table 29. North America Marine Biopharmaceutical Revenue by Application (2023-2028) & (US$ Million)
    Table 30. North America Marine Biopharmaceutical Revenue by Country (2017-2022) & (US$ Million)
    Table 31. North America Marine Biopharmaceutical Revenue by Country (2023-2028) & (US$ Million)
    Table 32. Europe Marine Biopharmaceutical Revenue by Company (2020-2022) & (US$ Million)
    Table 33. Europe Marine Biopharmaceutical Revenue by Type (2017-2022) & (US$ Million)
    Table 34. Europe Marine Biopharmaceutical Revenue by Type (2023-2028) & (US$ Million)
    Table 35. Europe Marine Biopharmaceutical Revenue by Application (2017-2022) & (US$ Million)
    Table 36. Europe Marine Biopharmaceutical Revenue by Application (2023-2028) & (US$ Million)
    Table 37. Europe Marine Biopharmaceutical Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Europe Marine Biopharmaceutical Revenue by Country (2023-2028) & (US$ Million)
    Table 39. Asia Pacific Marine Biopharmaceutical Revenue by Company (2020-2022) & (US$ Million)
    Table 40. Asia Pacific Marine Biopharmaceutical Revenue by Type (2017-2022) & (US$ Million)
    Table 41. Asia Pacific Marine Biopharmaceutical Revenue by Type (2023-2028) & (US$ Million)
    Table 42. Asia Pacific Marine Biopharmaceutical Revenue by Application (2017-2022) & (US$ Million)
    Table 43. Asia Pacific Marine Biopharmaceutical Revenue by Application (2023-2028) & (US$ Million)
    Table 44. Asia Pacific Marine Biopharmaceutical Revenue by Region (2017-2022) & (US$ Million)
    Table 45. Asia Pacific Marine Biopharmaceutical Revenue by Region (2023-2028) & (US$ Million)
    Table 46. Latin America Marine Biopharmaceutical Revenue by Company (2020-2022) & (US$ Million)
    Table 47. Latin America Marine Biopharmaceutical Revenue by Type (2017-2022) & (US$ Million)
    Table 48. Latin America Marine Biopharmaceutical Revenue by Type (2023-2028) & (US$ Million)
    Table 49. Latin America Marine Biopharmaceutical Revenue by Application (2017-2022) & (US$ Million)
    Table 50. Latin America Marine Biopharmaceutical Revenue by Application (2023-2028) & (US$ Million)
    Table 51. Latin America Marine Biopharmaceutical Revenue by Country (2017-2022) & (US$ Million)
    Table 52. Latin America Marine Biopharmaceutical Revenue by Country (2023-2028) & (US$ Million)
    Table 53. Middle East and Africa Marine Biopharmaceutical Revenue by Company (2020-2022) & (US$ Million)
    Table 54. Middle East and Africa Marine Biopharmaceutical Revenue by Type (2017-2022) & (US$ Million)
    Table 55. Middle East and Africa Marine Biopharmaceutical Revenue by Type (2023-2028) & (US$ Million)
    Table 56. Middle East and Africa Marine Biopharmaceutical Revenue by Application (2017-2022) & (US$ Million)
    Table 57. Middle East and Africa Marine Biopharmaceutical Revenue by Application (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Marine Biopharmaceutical Revenue by Country (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Marine Biopharmaceutical Revenue by Country (2023-2028) & (US$ Million)
    Table 60. Seattle Genetics Company Details
    Table 61. Seattle Genetics Business Overview
    Table 62. Seattle Genetics Marine Biopharmaceutical Product and Services
    Table 63. Seattle Genetics Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022) & (US$ Million)
    Table 64. Seattle Genetics Marine Biopharmaceutical SWOT Analysis
    Table 65. Seattle Genetics Recent Developments
    Table 66. DSM Company Details
    Table 67. DSM Business Overview
    Table 68. DSM Marine Biopharmaceutical Product and Services
    Table 69. DSM Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022) & (US$ Million)
    Table 70. DSM Marine Biopharmaceutical SWOT Analysis
    Table 71. DSM Recent Developments
    Table 72. Eisai Co Company Details
    Table 73. Eisai Co Business Overview
    Table 74. Eisai Co Marine Biopharmaceutical Product and Services
    Table 75. Eisai Co Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022) & (US$ Million)
    Table 76. Eisai Co Marine Biopharmaceutical SWOT Analysis
    Table 77. Eisai Co Recent Developments
    Table 78. Takeda Company Details
    Table 79. Takeda Business Overview
    Table 80. Takeda Marine Biopharmaceutical Product and Services
    Table 81. Takeda Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022) & (US$ Million)
    Table 82. Takeda Marine Biopharmaceutical SWOT Analysis
    Table 83. Takeda Recent Developments
    Table 84. BASF Company Details
    Table 85. BASF Business Overview
    Table 86. BASF Marine Biopharmaceutical Product and Services
    Table 87. BASF Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022) & (US$ Million)
    Table 88. BASF Marine Biopharmaceutical SWOT Analysis
    Table 89. BASF Recent Developments
    Table 90. Amway Company Details
    Table 91. Amway Business Overview
    Table 92. Amway Marine Biopharmaceutical Product and Services
    Table 93. Amway Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022) & (US$ Million)
    Table 94. Amway Marine Biopharmaceutical SWOT Analysis
    Table 95. Amway Recent Developments
    Table 96. Pfizer Company Details
    Table 97. Pfizer Business Overview
    Table 98. Pfizer Marine Biopharmaceutical Product and Services
    Table 99. Pfizer Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022) & (US$ Million)
    Table 100. Pfizer Marine Biopharmaceutical SWOT Analysis
    Table 101. Pfizer Recent Developments
    Table 102. Pelagia (EPAX) Company Details
    Table 103. Pelagia (EPAX) Business Overview
    Table 104. Pelagia (EPAX) Marine Biopharmaceutical Product and Services
    Table 105. Pelagia (EPAX) Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022) & (US$ Million)
    Table 106. Pelagia (EPAX) Marine Biopharmaceutical SWOT Analysis
    Table 107. Pelagia (EPAX) Recent Developments
    Table 108. Pharma Mar SA Company Details
    Table 109. Pharma Mar SA Business Overview
    Table 110. Pharma Mar SA Marine Biopharmaceutical Product and Services
    Table 111. Pharma Mar SA Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022) & (US$ Million)
    Table 112. Pharma Mar SA Marine Biopharmaceutical SWOT Analysis
    Table 113. Pharma Mar SA Recent Developments
    Table 114. Croda Company Details
    Table 115. Croda Business Overview
    Table 116. Croda Marine Biopharmaceutical Product and Services
    Table 117. Croda Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022) & (US$ Million)
    Table 118. Croda Marine Biopharmaceutical SWOT Analysis
    Table 119. Croda Recent Developments
    Table 120. GNC Company Details
    Table 121. GNC Business Overview
    Table 122. GNC Marine Biopharmaceutical Product and Services
    Table 123. GNC Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022) & (US$ Million)
    Table 124. GNC Recent Developments
    Table 125. GSK Company Details
    Table 126. GSK Business Overview
    Table 127. GSK Marine Biopharmaceutical Product and Services
    Table 128. GSK Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022) & (US$ Million)
    Table 129. GSK Recent Developments
    Table 130. TerSera Therapeutics Company Details
    Table 131. TerSera Therapeutics Business Overview
    Table 132. TerSera Therapeutics Marine Biopharmaceutical Product and Services
    Table 133. TerSera Therapeutics Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022) & (US$ Million)
    Table 134. TerSera Therapeutics Recent Developments
    Table 135. Nordic Naturals Company Details
    Table 136. Nordic Naturals Business Overview
    Table 137. Nordic Naturals Marine Biopharmaceutical Product and Services
    Table 138. Nordic Naturals Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022) & (US$ Million)
    Table 139. Nordic Naturals Recent Developments
    Table 140. Carlson Labs Company Details
    Table 141. Carlson Labs Business Overview
    Table 142. Carlson Labs Marine Biopharmaceutical Product and Services
    Table 143. Carlson Labs Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022) & (US$ Million)
    Table 144. Carlson Labs Recent Developments
    Table 145. Marine Biopharmaceutical Market Trends
    Table 146. Marine Biopharmaceutical Market Drivers
    Table 147. Marine Biopharmaceutical Market Challenges
    Table 148. Marine Biopharmaceutical Market Restraints
    Table 149. Research Programs/Design for This Report
    Table 150. Key Data Information from Secondary Sources
    Table 151. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Marine Biopharmaceutical Sales Market Share by Type: 2021 VS 2028
    Figure 2. Drugs Features
    Figure 3. Health Supplement Features
    Figure 4. Global Marine Biopharmaceutical Sales Market Share by Application: 2021 VS 2028
    Figure 5. Hospital & Clinic Case Studies
    Figure 6. Pharmacy Case Studies
    Figure 7. Other Case Studies
    Figure 8. Marine Biopharmaceutical Report Years Considered
    Figure 9. Global Marine Biopharmaceutical Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 10. Global Marine Biopharmaceutical Market Size 2017-2028 (US$ Million)
    Figure 11. Global Marine Biopharmaceutical Market Size Market Share by Region: 2021 VS 2028
    Figure 12. Global Marine Biopharmaceutical Revenue Market Share by Region in 2017 VS 2022
    Figure 13. Global Top 10 Marine Biopharmaceutical Countries Ranking by Market Size (US$ Million) in 2021
    Figure 14. Global Marine Biopharmaceutical Market Share by Players in 2021
    Figure 15. Global Top Marine Biopharmaceutical Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Marine Biopharmaceutical as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Marine Biopharmaceutical Revenue in 2021
    Figure 17. North America Marine Biopharmaceutical Revenue Market Share by Company in 2021
    Figure 18. North America Marine Biopharmaceutical Revenue Market Share by Type (2017-2028)
    Figure 19. North America Marine Biopharmaceutical Revenue Market Share by Application (2017-2028)
    Figure 20. North America Marine Biopharmaceutical Revenue Share by Country (2017-2028)
    Figure 21. United States Marine Biopharmaceutical Revenue (2017-2028) & (US$ Million)
    Figure 22. Canada Marine Biopharmaceutical Revenue (2017-2028) & (US$ Million)
    Figure 23. Europe Marine Biopharmaceutical Revenue Market Share by Company in 2021
    Figure 24. Europe Marine Biopharmaceutical Revenue Market Share by Type (2017-2028)
    Figure 25. Europe Marine Biopharmaceutical Revenue Market Share by Application (2017-2028)
    Figure 26. Europe Marine Biopharmaceutical Revenue Share by Country (2017-2028)
    Figure 27. Germany Marine Biopharmaceutical Revenue (2017-2028) & (US$ Million)
    Figure 28. France Marine Biopharmaceutical Revenue (2017-2028) & (US$ Million)
    Figure 29. U.K. Marine Biopharmaceutical Revenue (2017-2028) & (US$ Million)
    Figure 30. Italy Marine Biopharmaceutical Revenue (2017-2028) & (US$ Million)
    Figure 31. Russia Marine Biopharmaceutical Revenue (2017-2028) & (US$ Million)
    Figure 32. Asia Pacific Marine Biopharmaceutical Revenue Market Share by Company in 2021
    Figure 33. Asia Pacific Marine Biopharmaceutical Revenue Market Share by Type (2017-2028)
    Figure 34. Asia Pacific Marine Biopharmaceutical Revenue Market Share by Application (2017-2028)
    Figure 35. Asia Pacific Marine Biopharmaceutical Revenue Share by Region (2017-2028)
    Figure 36. China Marine Biopharmaceutical Revenue (2017-2028) & (US$ Million)
    Figure 37. Japan Marine Biopharmaceutical Revenue (2017-2028) & (US$ Million)
    Figure 38. South Korea Marine Biopharmaceutical Revenue (2017-2028) & (US$ Million)
    Figure 39. India Marine Biopharmaceutical Revenue (2017-2028) & (US$ Million)
    Figure 40. Australia Marine Biopharmaceutical Revenue (2017-2028) & (US$ Million)
    Figure 41. China Taiwan Marine Biopharmaceutical Revenue (2017-2028) & (US$ Million)
    Figure 42. Indonesia Marine Biopharmaceutical Revenue (2017-2028) & (US$ Million)
    Figure 43. Thailand Marine Biopharmaceutical Revenue (2017-2028) & (US$ Million)
    Figure 44. Malaysia Marine Biopharmaceutical Revenue (2017-2028) & (US$ Million)
    Figure 45. Latin America Marine Biopharmaceutical Revenue Market Share by Company in 2021
    Figure 46. Latin America Marine Biopharmaceutical Revenue Market Share by Type (2017-2028)
    Figure 47. Latin America Marine Biopharmaceutical Revenue Market Share by Application (2017-2028)
    Figure 48. Latin America Marine Biopharmaceutical Revenue Share by Country (2017-2028)
    Figure 49. Mexico Marine Biopharmaceutical Revenue (2017-2028) & (US$ Million)
    Figure 50. Brazil Marine Biopharmaceutical Revenue (2017-2028) & (US$ Million)
    Figure 51. Argentina Marine Biopharmaceutical Revenue (2017-2028) & (US$ Million)
    Figure 52. Middle East and Africa Marine Biopharmaceutical Revenue Market Share by Company in 2021
    Figure 53. Middle East and Africa Marine Biopharmaceutical Revenue Market Share by Type (2017-2028)
    Figure 54. Middle East and Africa Marine Biopharmaceutical Revenue Market Share by Application (2017-2028)
    Figure 55. Middle East and Africa Marine Biopharmaceutical Revenue Share by Country (2017-2028)
    Figure 56. Turkey Marine Biopharmaceutical Revenue (2017-2028) & (US$ Million)
    Figure 57. Saudi Arabia Marine Biopharmaceutical Revenue (2017-2028) & (US$ Million)
    Figure 58. UAE Marine Biopharmaceutical Revenue (2017-2028) & (US$ Million)
    Figure 59. Seattle Genetics Revenue Growth Rate in Marine Biopharmaceutical Business (2017-2022)
    Figure 60. DSM Revenue Growth Rate in Marine Biopharmaceutical Business (2017-2022)
    Figure 61. Eisai Co Revenue Growth Rate in Marine Biopharmaceutical Business (2017-2022)
    Figure 62. Takeda Revenue Growth Rate in Marine Biopharmaceutical Business (2017-2022)
    Figure 63. BASF Revenue Growth Rate in Marine Biopharmaceutical Business (2017-2022)
    Figure 64. Amway Revenue Growth Rate in Marine Biopharmaceutical Business (2017-2022)
    Figure 65. Pfizer Revenue Growth Rate in Marine Biopharmaceutical Business (2017-2022)
    Figure 66. Pelagia (EPAX) Revenue Growth Rate in Marine Biopharmaceutical Business (2017-2022)
    Figure 67. Pharma Mar SA Revenue Growth Rate in Marine Biopharmaceutical Business (2017-2022)
    Figure 68. Croda Revenue Growth Rate in Marine Biopharmaceutical Business (2017-2022)
    Figure 69. GNC Revenue Growth Rate in Marine Biopharmaceutical Business (2017-2022)
    Figure 70. GSK Revenue Growth Rate in Marine Biopharmaceutical Business (2017-2022)
    Figure 71. TerSera Therapeutics Revenue Growth Rate in Marine Biopharmaceutical Business (2017-2022)
    Figure 72. Nordic Naturals Revenue Growth Rate in Marine Biopharmaceutical Business (2017-2022)
    Figure 73. Carlson Labs Revenue Growth Rate in Marine Biopharmaceutical Business (2017-2022)
    Figure 74. Bottom-up and Top-down Approaches for This Report
    Figure 75. Data Triangulation
    Figure 76. Key Executives Interviewed

Keyplayers in Global Marine Biopharmaceutical Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Seattle Genetics
DSM
Eisai Co
Takeda
BASF
Amway
Pfizer
Pelagia (EPAX)
Pharma Mar SA
Croda
GNC
GSK
TerSera Therapeutics
Nordic Naturals
Carlson Labs

REQUEST SUMMARY

Request Sample

Pre-order Enquiry

Request Discount

Contact Information

24/7 Research Support

Phone: +1 424 253 0807

[email protected]